Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

3.70
-0.0900-2.37%
Post-market: 4.200.5000+13.51%18:32 EDT
Volume:2.57K
Turnover:9.92K
Market Cap:3.38M
PE:-0.71
High:4.11
Open:3.75
Low:3.70
Close:3.79
Loading ...
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 05, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 02, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 04, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 28, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 03, 2022

Major Issues Report

8-K - Current report
Jan 24, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 29, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report